{"id":116251,"date":"2010-03-24T00:00:00","date_gmt":"2010-03-24T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/report\/hpwpexecutivebriefing0310-marketaccess-executive-briefing-healthcare-reform-bill-what\/"},"modified":"2010-03-24T00:00:00","modified_gmt":"2010-03-24T00:00:00","slug":"hpwpexecutivebriefing0310-marketaccess-executive-briefing-healthcare-reform-bill-what","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/hpwpexecutivebriefing0310-marketaccess-executive-briefing-healthcare-reform-bill-what\/","title":{"rendered":"Executive Briefing | Healthcare Reform Bill: What It Means For Managed Markets | March 2010"},"content":{"rendered":"<p>HealthLeaders-InterStudy has prepared an executive brief on healthcare reform outlining how the Medicare, Medicaid and individual insurance markets will be affected, and what these changes mean for the pharmaceutical industry.<\/p>\n","protected":false},"template":"","class_list":["post-116251","report","type-report","status-publish","hentry","report-gateway-marketaccess","marketaccess-date-566"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/116251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":0,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/116251\/revisions"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=116251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}